© 2020 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
Latest Conference Articles
Dr Lametra Scott Discusses Cost, Formulary Guidance in Managing Sickle Cell Disease
October 23rd 2020, 8:42pm
AMCP Nexus: The Academy of Managed Care Pharmacy Nexus
While sickle cell disease is not prevalent in the general population, the significant cost associated with the condition warrants action from payers and formulary decision makers to improve patient access and align cost with their budgetary goals.
Areas to Watch in Specialty Drug Pipeline Include Cancer, Orphan Drugs
October 23rd 2020, 8:35pm
AMCP Nexus: The Academy of Managed Care Pharmacy Nexus
In her presentation, Aimee Tharaldson, PhD, senior clinical pharmacist of emerging therapeutics at Express Scripts, discussed the upcoming pipeline of specialty drug approvals and their potential impact on the market.
Dr Aimee Tharaldson Outlines the Pipeline, Role of Emerging Specialty Medications
October 23rd 2020, 6:45pm
AMCP Nexus: The Academy of Managed Care Pharmacy Nexus
In the current pipeline of specialty medications seeking approval, a majority of development lies within orphan drugs and cancer medications, said Aimee Tharaldson, PharmD, of Express Scripts.
Akebia Therapeutics' CEO on Mechanisms of HIF-PHI Candidate
October 23rd 2020, 3:00pm
Vadadustat is an investigational drug belonging to a class known as hypoxia-inducible prolyl hydroxylase inhibitors (HIF-PHIs) for the treatment of anemia in chronic kidney disease.
Dr Rajiv Agarwal Discusses Finerenone, Results of FIDELIO-DKD
October 23rd 2020, 2:30pm
The investigational drug finerenone met its primary endpoint in FIDELIO-DKD of slowing progression of chronic kidney disease (CKD) in patients with type 2 diabetes and CKD, said Rajiv Agarwal, MD, MS, FASN, a professor of medicine at Indiana University School of Medicine and a staff physician at the Veterans Affairs Medical Center in Indianapolis, Indiana.
Understanding the Complicated Patchwork of State Drug Pricing Reform Legislation
October 23rd 2020, 2:00pm
AMCP Nexus: The Academy of Managed Care Pharmacy Nexus
The pressure on state budgets exerted by new approvals of costly therapeutics has led many states to implement legislation aimed at regulating drug prices, but the success of these efforts is not uniform across the nation.
Communicating Bad News Effectively and Compassionately in the ICU
October 23rd 2020, 1:15pm
During a session at CHEST 2020, Robyn Scatena, MD, director of critical care at Norwalk Hospital, outlined 2 communication models to help break bad news in the intensive care unit (ICU).
Risks of Developing Delirium in ICU Patients With COVID-19
October 22nd 2020, 10:15pm
Rates of delirium for patients in the intensive care unit (ICU) have skyrocketed in the coronavirus disease 2019 (COVID-19) pandemic, said Brenda Truman Pun, DNP, RN, director of data quality, Vanderbilt Critical Illness, Brain Dysfunction, and Survivorship Center.
Session Highlights Long-term Skeletal Effects of Kidney Diseases
October 22nd 2020, 9:30pm
Experts presenting the American Society of Nephrology’s Kidney Week session entitled “From Kids to Adults: Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Across the Life Course,” outlined the detrimental effects of childhood CKD and other kidney diseases on long-term health.
Melissa Andel on Legislative Efforts, Unmet Needs for State-Level Prescription Drug Pricing Reform
October 22nd 2020, 8:54pm
AMCP Nexus: The Academy of Managed Care Pharmacy Nexus
Americans not covered by Medicaid should be aware of 2 key factors: the use of copay accumulators in commercial health plans and management of emerging high-cost specialty prescription drugs.